Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Clinical trial NCT06795412 · RECRUITING

Trial details

NCT number: NCT06795412
Sponsor: Pyxis Oncology, Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-04-15
Primary completion: 2027-12-06
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.